As of May 14, 2026, Unicycive Therapeutics's top three insider holders are Gaurav Aggarwal (Director, 3.47Mn shares), Shalabh K. Gupta (Ceo, 2.53Mn shares), Gaurav Aggarwal (Director, 1.79Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Gaurav Aggarwal | - | 0 | 3,470,152 | 13 Jul, 2023 |
| Shalabh K. Gupta | Ceo | 2,527,449 | 0 | 13 Jul, 2023 |
| Gaurav Aggarwal | - | 0 | 1,789,915 | 26 Aug, 2025 |
| Douglas Jermasek | Evp Of Corporate Strategy | 175,012 | 0 | 13 Jul, 2023 |
| Pramod Gupta | Evp, Pharmaceuticals And Bd | 41,845 | 0 | 13 Jul, 2023 |
| Brigitte Schiller | - | 26,738 | 0 | 30 Aug, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 25 Aug, 2025 | Gaurav Aggarwal | Common Stock | A | 652,900 | - | 1,789,915 | I | C |
| 25 Aug, 2025 | Gaurav Aggarwal | Series A-2 Prime Preferred Stock | D | 3,199 | $1,000.00 | 0 | I | D |
| 28 Jul, 2025 | Pramod Gupta | Stock Options | A | 90,000 | $0.00 | 301,986 | D | A |
| 28 Jul, 2025 | Shalabh K. Gupta | Stock Options | A | 325,000 | $0.00 | 968,951 | D | A |
| 28 Jul, 2025 | John Townsend | Stock Options | A | 10,000 | $0.00 | 101,557 | D | A |
| 28 Jul, 2025 | Sandeep Laumas | Stock Options | A | 21,200 | $0.00 | 41,286 | D | A |
| 28 Jul, 2025 | Gaurav Aggarwal | Stock Options | A | 21,200 | $0.00 | 39,200 | D | A |
| 28 Jul, 2025 | Sara Kenkare-Mitra | Stock Options | A | 21,200 | $0.00 | 39,200 | D | A |
| 28 Jul, 2025 | Douglas Jermasek | Stock Options | A | 10,000 | $0.00 | 215,500 | D | A |
| 18 Feb, 2025 | Gaurav Aggarwal | Common Stock | A | 1,400,000 | - | 11,370,152 | I | C |
| 18 Feb, 2025 | Gaurav Aggarwal | Series A-2 Prime Preferred Stock | D | 686 | $1,000.00 | 3,119 | I | D |
| 09 Oct, 2024 | Gaurav Aggarwal | Common Stock | A | 5,500,000 | - | 9,970,152 | I | C |
| 09 Oct, 2024 | Gaurav Aggarwal | Series A-2 Prime Preferred Stock | D | 2,695 | $1,000.00 | 3,885 | I | D |
| 12 Aug, 2024 | Shalabh K. Gupta | Stock Options | A | 232,868 | $0.00 | 6,439,505 | D | A |
| 12 Aug, 2024 | John Townsend | Stock Options | A | 40,256 | $0.00 | 915,565 | D | A |
| 12 Aug, 2024 | Pramod Gupta | Stock Options | A | 81,750 | $0.00 | 2,119,862 | D | A |
| 12 Aug, 2024 | Douglas Jermasek | Stock Options | A | 81,750 | $0.00 | 2,055,000 | D | A |
| 15 Apr, 2024 | Shalabh K. Gupta | Stock Options | A | 1,319,583 | $0.00 | 6,206,637 | D | A |
| 15 Apr, 2024 | John Townsend | Stock Options | A | 228,119 | $0.00 | 875,309 | D | A |
| 15 Apr, 2024 | Pramod Gupta | Stock Options | A | 463,250 | $0.00 | 2,038,112 | D | A |